BARINTHUS BIOTHERAPEUTICS PL (BRNS) Stock Income Statement
NASDAQ:BRNS - Nasdaq - US91864C1071 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.97M | 14.97M | 802.00K | 44.70M | 268.00K | |||
| Minority Interest Expense | 88.00K | 109.00K | 100.00K | 21.00K | 247.00K | |||
| Operating Expenses | 74.42M | 65.43M | 84.72M | 48.74M | 45.49M | |||
| Research and Development | 39.40M | 42.24M | 44.87M | 42.35M | 20.37M | |||
| Selling, General, and Administrative Expenses | 36.31M | 24.37M | 39.84M | 6.39M | 25.12M | |||
| Operating Income | -59.45M | -50.46M | -83.91M | -4.04M | -45.22M | |||
| Interest Income/Expense | 2.40M | 2.63M | 2.85M | 3.08M | 3.54M | |||
| Other Income/Expense | 3.90M | 4.12M | 4.54M | 1.81M | 4.33M | |||
| Non Recurring Items | N/A | -17.51M | N/A | 0.00 | -13.79M | |||
| Income Before Taxes | -65.35M | -61.23M | -76.52M | 850.00K | -51.14M | |||
| Income Tax | -29.00K | -44.00K | -3.08M | -4.47M | -28.00K | |||
| Net Income | -65.23M | -61.07M | -73.35M | 5.34M | -50.87M | |||
| EBITDA | -53.04M | -44.66M | -78.48M | 282.00K | -44.62M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.64 | -1.55 | -1.91 | 0.14 | -1.37 | |||
| Non GAAP EPS | -1.64 | -1.55 | -1.92 | 0.13 | -2.10 | |||
| Statistics | ||||||||
| Profit Margin | -435.79% | -408.00% | -9145.51% | 11.95% | -18979.48% | |||
| Operating Profit Margin | -397.13% | -337.10% | -10463.09% | -9.04% | -16873.51% | |||
All data in USD